Low molecular weight heparin and cancer survival: clinical trials and experimental mechanisms

被引：0
|
作者：
Ning Zhang
Weihua Lou
Fang Ji
Lihua Qiu
Benjamin K. Tsang
Wen Di
机构：
[1] Shanghai JiaoTong University,Department of Obstetrics and Gynecology, Ren Ji Hospital, School of Medicine
[2] Shanghai Key Laboratory of Gynecologic Oncology,Macau Institute for Applied Research in Medicine and Health3, State Key laboratory of Quality Research in Chinese Medicine
[3] Macau University of Science and Technology,Department of Obstetrics & Gynecology and Cellular & Molecular Medicine, Interdisciplinary School of Health Sciences, University of Ottawa, and Chronic Diseases Program
[4] Ottawa Hospital Research Institute,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2016年 / 142卷
关键词：
Cancer; Low molecular weight heparin; Survival; Randomized trial; Molecular mechanisms;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1807 / 1816
页数：9
相关论文
共 50 条
  • [1] Low molecular weight heparin and cancer survival: clinical trials and experimental mechanisms
    Zhang, Ning
    Lou, Weihua
    Ji, Fang
    Qiu, Lihua
    Tsang, Benjamin K.
    Di, Wen
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (08) : 1807 - 1816
  • [2] The effect of low molecular weight heparin on survival in patients with cancer
    Saynak, Mert
    Yurut-Caloglu, Vuslat
    Bayir, Gulden
    Caloglu, Murat
    Uzal, Cem
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2006, 21 (01): : 42 - 46
  • [3] Low-molecular-weight heparin and survival in lung cancer
    Noble, Simon
    THROMBOSIS RESEARCH, 2012, 129 : S114 - S118
  • [4] Cancer survival: Which low molecular weight heparin (LMWH) is best?
    Spahr, J. E.
    Akerley, W.
    Rodgers, G. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] LOW-MOLECULAR-WEIGHT HEPARIN - A CRITICAL ANALYSIS OF CLINICAL-TRIALS
    GREEN, D
    HIRSH, J
    HEIT, J
    PRINS, M
    DAVIDSON, B
    LENSING, AWA
    PHARMACOLOGICAL REVIEWS, 1994, 46 (01) : 89 - 109
  • [6] CLINICAL-TRIALS WITH LOW-MOLECULAR-WEIGHT HEPARIN IN VENOUS THROMBOSIS
    TURPIE, AGG
    THROMBOSIS RESEARCH, 1986, : 67 - 67
  • [7] Low molecular weight heparin (LMWH) therapy and survival in advanced cancer.
    Kakkar, AK
    Kadziola, Z
    Williamson, RCN
    Levine, MN
    Low, V
    Lemoine, NR
    BLOOD, 2002, 100 (11) : 148A - 148A
  • [8] Low-molecular-weight heparin and cancer
    Zacharski, LR
    Ornstein, DL
    Mamourian, AC
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 : 69 - 77
  • [9] Assessment of low-molecular-weight heparin trials in cardiology
    Shulmann, RI
    PHARMACOLOGY & THERAPEUTICS, 2000, 87 (01) : 1 - 9
  • [10] The effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trials
    Lazo-Langner, A.
    Goss, G. D.
    Spaans, J. N.
    Rodger, M. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (04) : 729 - 737
12345